114 related articles for article (PubMed ID: 24961129)
1. [Neoplasms stem cells play an important role in resistance of laryngeal squamous cancer to chemoradiotherapy].
Han R; Huangfu H; Gao W; Zhang C; Jin Y; Li Z; Wang B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):400-5. PubMed ID: 24961129
[TBL] [Abstract][Full Text] [Related]
2. [Synergistic lethal effects of cetuximab combined with chemotherapy and/or radiotherapy in laryngeal squamous carcinoma cells].
Han R; Huangfu H; Gao W; Zhang C; Wang N; Li Z; Wang B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Dec; 27(24):1375-80. PubMed ID: 24669690
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro.
Wang M; Li X; Qu Y; Xu O; Sun Q
Int J Oncol; 2013 Jul; 43(1):131-40. PubMed ID: 23652853
[TBL] [Abstract][Full Text] [Related]
4. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
Wei XD; Zhou L; Cheng L; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
[TBL] [Abstract][Full Text] [Related]
6. [Lentivirus-mediated RNA interference of CD133 inhibits the proliferation of CD133(+) liver cancer stem cells and increases their cisplatin chemosensitivity].
Lan X; Wang Y; Cao S; Zou D; Li F; Li S
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1741-7. PubMed ID: 23268401
[TBL] [Abstract][Full Text] [Related]
7. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
[TBL] [Abstract][Full Text] [Related]
9. [Isolation and in vivo tumorigenicity assay of CD133+ side population cells from laryngeal cancer cell line].
Wu CP; Zhou L; Xie M; Tao L; Zhang M; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):223-7. PubMed ID: 22805024
[TBL] [Abstract][Full Text] [Related]
10. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
[TBL] [Abstract][Full Text] [Related]
11. [Isolation and in vitro characterization of CD133(+) side population cells from laryngeal cancer cell line].
Wu CP; Zhou L; Xie M; Tao L; Zhang M; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):752-7. PubMed ID: 22177045
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
13. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.
Yano S; Tazawa H; Hashimoto Y; Shirakawa Y; Kuroda S; Nishizaki M; Kishimoto H; Uno F; Nagasaka T; Urata Y; Kagawa S; Hoffman RM; Fujiwara T
Clin Cancer Res; 2013 Dec; 19(23):6495-505. PubMed ID: 24081978
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.
Yu D; Liu Y; Yang J; Jin C; Zhao X; Cheng J; Liu X; Qi X
Cell Biochem Biophys; 2015 Jan; 71(1):261-9. PubMed ID: 25241082
[TBL] [Abstract][Full Text] [Related]
15. [Impacts of hypoxia on the features and chemoresistance of cancer stem cells in Hep-2 cells and underlying mechanism].
Qu YT; Li XM; Xu O; Wang MX; Lu XY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):228-33. PubMed ID: 22805025
[TBL] [Abstract][Full Text] [Related]
16. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
[TBL] [Abstract][Full Text] [Related]
17. CD133, one of the markers of cancer stem cells in Hep-2 cell line.
Zhou L; Wei X; Cheng L; Tian J; Jiang JJ
Laryngoscope; 2007 Mar; 117(3):455-60. PubMed ID: 17334305
[TBL] [Abstract][Full Text] [Related]
18. [Investigation on biological characteristics of CD133+ cancer stem cells in human laryngeal carcinoma Hep-2 cell line].
Wei XD; He J; Gao JX; Wang JY; Ma BJ; Chen J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jul; 48(7):578-83. PubMed ID: 24313208
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of self-renewal mechanism about CD133+ cancer stem cells in human laryngeal carcinoma Hep-2 cell line].
Wei X; He J; Gao J; Chen J; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Nov; 28(21):1636-41. PubMed ID: 25735089
[TBL] [Abstract][Full Text] [Related]
20. Identification and Characterization of CD133(pos) Subpopulation Cells From a Human Laryngeal Cancer Cell Line.
Qiu HO; Wang H; Che N; Li D; Mao Y; Zeng Q; Ge R
Med Sci Monit; 2016 Apr; 22():1146-51. PubMed ID: 27049928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
